Clinical Trial Update: Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of Newborn [NA]

View source ↗

Summary

A clinical trial in Saudi Arabia is investigating the safe threshold to discontinue phototherapy for hemolytic disease of the newborn in neonates with hyperbili…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemolytic Disease of the Newborn
• Neonatal Hyperbilirubinemia

Snippet

Sponsor: Ministry of Health, Saudi Arabia | Conditions: Hemolytic Disease of Newborn, Neonatal Hyperbilirubinemia | NA | Status: RECRUITING